Mendelian randomization for studying the effects of perturbing drug targets

Drugs whose targets have genetic evidence to support efficacy and safety are more likely to be approved after clinical development. In this paper, we provide an overview of how natural sequence variation in the genes that encode drug targets can be used in Mendelian randomization analyses to offer i...

Descripción completa

Detalles Bibliográficos
Autores principales: Gill, Dipender, Georgakis, Marios K., Walker, Venexia M., Schmidt, A. Floriaan, Gkatzionis, Apostolos, Freitag, Daniel F., Finan, Chris, Hingorani, Aroon D., Howson, Joanna M.M., Burgess, Stephen, Swerdlow, Daniel I., Davey Smith, George, Holmes, Michael V., Dichgans, Martin, Scott, Robert A, Zheng, Jie, Psaty, Bruce M., Davies, Neil M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903200/
https://www.ncbi.nlm.nih.gov/pubmed/33644404
http://dx.doi.org/10.12688/wellcomeopenres.16544.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903200/
https://www.ncbi.nlm.nih.gov/pubmed/33644404
http://dx.doi.org/10.12688/wellcomeopenres.16544.2

Ejemplares similares